Provided by Tiger Trade Technology Pte. Ltd.

KALA BIO

1.10
-0.2300-17.29%
Post-market: 1.140.0393+3.57%17:43 EST
Volume:6.22M
Turnover:7.62M
Market Cap:9.03M
PE:-0.19
High:1.37
Open:1.23
Low:1.10
Close:1.33
52wk High:20.60
52wk Low:0.6076
Shares:8.21M
Float Shares:8.15M
Volume Ratio:0.15
T/O Rate:76.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8254
EPS(LYR):-10.1450
ROE:-708.34%
ROA:-65.81%
PB:-1.04
PE(LYR):-0.11

Loading ...

Top Midday Gainers

MT Newswires Live
·
Yesterday

KALA BIO Inc: Continuing to Evaluate and Redevelop Co's Product Candidates While Actively Exploring Strategic Opportunities

THOMSON REUTERS
·
Dec 01

KALA BIO Inc - David E. Lazar Appointed as Kala's CEO and Chairman

THOMSON REUTERS
·
Dec 01

KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

GlobeNewswire
·
Dec 01

Kala Bio Inc. Files Initial Statement of Beneficial Ownership for CEO and Director David E. Lazar

Reuters
·
Nov 27

What Sparked KALA BIO's Nearly 38% Surge Overnight?

Benzinga
·
Nov 26

BRIEF-Kala Bio Inc - On Nov 21, Board Terminated Without Cause The Employment Of Mary Reumuth, Company's Chief Financial Officer

Reuters
·
Nov 26

KALA BIO Raises $1.8M in Preferred Stock Offering

TIPRANKS
·
Nov 26

KALA BIO Inc - on Nov 21, Board Terminated Without Cause the Employment of Mary Reumuth, Company's Chief Financial Officer

THOMSON REUTERS
·
Nov 26

KALA BIO Inc - on Nov 21, Board Appointed David Lazar as CEO of Co

THOMSON REUTERS
·
Nov 26

Kala Bio Inc. Announces $6 Million Private Placement of Preferred Shares

Reuters
·
Nov 26

Kala Bio Q3 EPS $(1.07) Beats $(1.45) Estimate

Benzinga
·
Nov 19

Top News Today: Stocks Mixed as AI Selloff Slows

Dow Jones
·
Nov 15

Kala Bio Delays Quarterly Financial Report Filing

Reuters
·
Nov 15

KALA BIO Inc - on Nov 10, Received Nasdaq Deficiency Letter for Non-Compliance - SEC Filing

THOMSON REUTERS
·
Nov 13

Kala Bio Faces Nasdaq Delisting Risk Over Market Value Compliance

Reuters
·
Nov 13

Kala Bio Secures $375,000 Convertible Loan from Private Investor

Reuters
·
Nov 10

KALA BIO Inc expected to post a loss of $1.45 a share - Earnings Preview

Reuters
·
Nov 07

Kala Bio CFO Mary Reumuth Reports Disposal of Common Shares

Reuters
·
Oct 25

Kala Bio Inc. Director Todd Bazemore Reports Disposal of Common Shares

Reuters
·
Oct 25